DE69126977T2 - Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier - Google Patents

Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier

Info

Publication number
DE69126977T2
DE69126977T2 DE69126977T DE69126977T DE69126977T2 DE 69126977 T2 DE69126977 T2 DE 69126977T2 DE 69126977 T DE69126977 T DE 69126977T DE 69126977 T DE69126977 T DE 69126977T DE 69126977 T2 DE69126977 T2 DE 69126977T2
Authority
DE
Germany
Prior art keywords
leukoregulin
treatment
animals infected
envelope virus
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69126977T
Other languages
English (en)
Other versions
DE69126977D1 (de
Inventor
John Hooks
Charles Evans
Barbara Detrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Publication of DE69126977D1 publication Critical patent/DE69126977D1/de
Application granted granted Critical
Publication of DE69126977T2 publication Critical patent/DE69126977T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69126977T 1990-05-11 1991-05-10 Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier Expired - Fee Related DE69126977T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/521,706 US5368853A (en) 1990-05-11 1990-05-11 Leukoregulin anti-viral therapy
PCT/US1991/003239 WO1991018014A1 (en) 1990-05-11 1991-05-10 Anti-viral therapy

Publications (2)

Publication Number Publication Date
DE69126977D1 DE69126977D1 (de) 1997-08-28
DE69126977T2 true DE69126977T2 (de) 1997-11-27

Family

ID=24077805

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69126977T Expired - Fee Related DE69126977T2 (de) 1990-05-11 1991-05-10 Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier

Country Status (11)

Country Link
US (2) US5368853A (de)
EP (1) EP0531341B1 (de)
JP (1) JPH0768136B2 (de)
AT (1) ATE155795T1 (de)
AU (1) AU644661B2 (de)
CA (1) CA2082270C (de)
DE (1) DE69126977T2 (de)
DK (1) DK0531341T3 (de)
ES (1) ES2103811T3 (de)
GR (1) GR3024236T3 (de)
WO (1) WO1991018014A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy
EP1350113A2 (de) 2000-08-30 2003-10-08 Chemocentryx, Inc. Inhibierung von cmv-infektionen und -ausstreuung
CA2437201C (en) 2001-02-02 2008-11-18 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
US7172085B2 (en) * 2001-12-04 2007-02-06 Beaudette Susan A Squeezable, fillable feeding device
WO2018035046A1 (en) 2016-08-15 2018-02-22 President And Fellows Of Harvard College Treating infections using idsd from proteus mirabilis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US5082657A (en) * 1984-04-13 1992-01-21 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
US4849506A (en) * 1984-04-13 1989-07-18 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
EP0230574A3 (de) * 1986-01-31 1989-03-22 Yale University Pharmazeutische Zusammensetzungen gegen durch LAV/HTLV-III-Virus verursachte Infektionen und ihre Verwendung
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy

Also Published As

Publication number Publication date
AU7873391A (en) 1991-12-10
EP0531341A1 (de) 1993-03-17
US5368853A (en) 1994-11-29
EP0531341A4 (en) 1993-07-28
DE69126977D1 (de) 1997-08-28
JPH0768136B2 (ja) 1995-07-26
CA2082270A1 (en) 1991-11-12
DK0531341T3 (da) 1997-09-22
WO1991018014A1 (en) 1991-11-28
CA2082270C (en) 1996-12-10
ES2103811T3 (es) 1997-10-01
US5529771A (en) 1996-06-25
GR3024236T3 (en) 1997-10-31
ATE155795T1 (de) 1997-08-15
EP0531341B1 (de) 1997-07-23
AU644661B2 (en) 1993-12-16
JPH05508834A (ja) 1993-12-09

Similar Documents

Publication Publication Date Title
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
EA199901031A1 (ru) Производные бензимидазола
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
EA199700215A1 (ru) Защита от вирусных инфекций путем колонизации слизистых оболочек генетически модифицированными бактериями
DE69323183D1 (de) Weitere indolderivate mit antiviraler wirkung
ATE189394T1 (de) Methode zur behandlung von viralen infektionen
DE3751772T2 (de) Impfstoff zur behandlung von hsv
DE69126977D1 (de) Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
BR9306207A (pt) Composiçao farmacéutica e processo para o tratamento de infecçao ou doença causada pelo vírus da hepatite b processo para a preparaçao da composiçao e uso de fiau ou de uma pró-droga ou metabolito do mesmo
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
DE69231465T2 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
DE69006187D1 (de) Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren.
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE69112392T2 (de) Bcrf1-antagonisten zur behandlung von epstein-barr-virus-infektionen.
DE59003111D1 (de) Arzneimittel und ihre Verwendung zur Behandlung von Parasitosen.
GB2125700A (en) Anti-viral treatment method
MY101495A (en) Treatment of diseases caused by viruses
TW217986B (en) Compositions for the treatment of infection and disease caused by HBV
BR8404558A (pt) Tratamento de doencas causadas pelos virus do herpes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee